TCNNF
Price
$6.57
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
131 days until earnings call
VEXTF
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
Ad is loading...

TCNNF vs VEXTF

Header iconTCNNF vs VEXTF Comparison
Open Charts TCNNF vs VEXTFBanner chart's image
Trulieve Cannabis
Price$6.57
Change-$0.00 (-0.00%)
Volume$609.51K
CapitalizationN/A
Vext Science
Price$0.13
Change-$0.00 (-0.00%)
Volume$18.96K
CapitalizationN/A
TCNNF vs VEXTF Comparison Chart
Loading...
View a ticker or compare two or three
VS
TCNNF vs. VEXTF commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TCNNF is a Sell and VEXTF is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (TCNNF: $6.57 vs. VEXTF: $0.13)
Brand notoriety: TCNNF and VEXTF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: TCNNF: 110% vs. VEXTF: 49%
Market capitalization -- TCNNF: $788.54M vs. VEXTF: $16.31M
TCNNF [@Pharmaceuticals: Other] is valued at $788.54M. VEXTF’s [@Pharmaceuticals: Other] market capitalization is $16.31M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TCNNF’s FA Score shows that 1 FA rating(s) are green whileVEXTF’s FA Score has 1 green FA rating(s).

  • TCNNF’s FA Score: 1 green, 4 red.
  • VEXTF’s FA Score: 1 green, 4 red.
According to our system of comparison, VEXTF is a better buy in the long-term than TCNNF.

Price Growth

TCNNF (@Pharmaceuticals: Other) experienced а -15.44% price change this week, while VEXTF (@Pharmaceuticals: Other) price change was -2.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -5.00%. For the same industry, the average monthly price growth was -7.81%, and the average quarterly price growth was -7.79%.

Reported Earning Dates

TCNNF is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-5.00% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

FUNDAMENTALS
Fundamentals
TCNNF($789M) has a higher market cap than VEXTF($16.3M). TCNNF has higher P/E ratio than VEXTF: TCNNF (120.48) vs VEXTF (3.80). TCNNF YTD gains are higher at: 26.104 vs. VEXTF (-38.680). TCNNF has higher annual earnings (EBITDA): 187M vs. VEXTF (10.1M). TCNNF has more cash in the bank: 188M vs. VEXTF (3.45M). VEXTF has less debt than TCNNF: VEXTF (39.8M) vs TCNNF (1.02B). TCNNF has higher revenues than VEXTF: TCNNF (1.21B) vs VEXTF (33.7M).
TCNNFVEXTFTCNNF / VEXTF
Capitalization789M16.3M4,840%
EBITDA187M10.1M1,851%
Gain YTD26.104-38.680-67%
P/E Ratio120.483.803,169%
Revenue1.21B33.7M3,593%
Total Cash188M3.45M5,456%
Total Debt1.02B39.8M2,570%
FUNDAMENTALS RATINGS
TCNNF: Fundamental Ratings
TCNNF
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
87
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
25
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

TCNNF and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCNNF has been closely correlated with GTBIF. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if TCNNF jumps, then GTBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCNNF
1D Price
Change %
TCNNF100%
-6.28%
GTBIF - TCNNF
82%
Closely correlated
-4.21%
CURLF - TCNNF
78%
Closely correlated
-1.79%
VRNOF - TCNNF
76%
Closely correlated
-7.29%
CRLBF - TCNNF
76%
Closely correlated
-2.78%
TSNDF - TCNNF
75%
Closely correlated
-2.00%
More

VEXTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, VEXTF has been loosely correlated with TCNNF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if VEXTF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VEXTF
1D Price
Change %
VEXTF100%
N/A
TCNNF - VEXTF
38%
Loosely correlated
-6.28%
CURLF - VEXTF
36%
Loosely correlated
-1.79%
AYRWF - VEXTF
35%
Loosely correlated
-9.30%
GTBIF - VEXTF
34%
Loosely correlated
-4.21%
GLASF - VEXTF
31%
Poorly correlated
-1.36%
More